PCG
PRAX icon

Private Capital Group’s Praxis Precision Medicines PRAX Stock Holding History

Private Capital Group’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2
Closed -$1K – 2165
2021
Q1 		$1K Buy
+2
New +$1.42K ﹤0.01% 1920

Other funds holding PRAX

Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Private Capital Group's PRAX Position: Q2 2021 in Review

Private Capital Group sold out of Praxis Precision Medicines (PRAX) in Q2 2021, closing a stake of 2 shares — an estimated $1K sold.

Private Capital Group first reported a position in PRAX in Q1 2021 and held it in 1 quarter. The position peaked at $1K in Q1 2021. 80 funds tracked by Wall St. Rank hold PRAX as of Q2 2021.

  • Private Capital Group reported no remaining Praxis Precision Medicines position as of Q2 2021 after selling out during the quarter.
  • Private Capital Group sold 2 Praxis Precision Medicines shares in Q2 2021, an estimated $1K.
  • Private Capital Group first reported a position in Praxis Precision Medicines in Q1 2021 and held it in 1 quarter.
  • Private Capital Group's Praxis Precision Medicines position peaked at $1K in Q1 2021.
  • 80 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2021.

Based on Private Capital Group's 13F filing for Q2 2021, filed 26 Jul 2021.